Welcome!
UOB Kay Hian
Broker's Calls
Seatrium slowly but surely bottoming out, more prominent earnings turnaround could be expected from 2024 onwards
The robust order pipeline and upcoming investor day for sharing the strategic review on March 15 are near-term catalysts.
February 27, 2024
Broker's Calls
Netlink's 3QFY2024 results in line with expectations, analysts keep “buy”
Netlink has sufficient debt headroom to drive its acquisition ambition without compromising on cash flow and dividends.
February 08, 2024
Broker's Calls
Analysts mixed on Mapletree Logistics Trust on near-term headwinds and easing occupancy
China’s leasing environment will remain challenging, with negative reversions expected to persist over the next few quarters.
January 29, 2024
Broker's Calls
UOB Kay Hian initiates ‘buy’ on Keppel DC REIT with TP of $2.10
The analysts see more potential from the REIT as AI becomes more deeply integrated into our daily lives.
January 11, 2024
Broker's Calls
UOB Kay Hian keeps ‘buy’ call on SATS, expects recovery via increased travel and cargo
SATS's 3QFY2024 earnings look poised to grow thanks to the continued recovery in air travel and cargo activities.
January 10, 2024
Broker's Calls
UOBKH adds CLAS and SATS, drops RH Petrogas, SIA Engineering and FEHT from alpha picks
UOBKH’s alpha picks portfolio outpaced the STI in 4QFY2023 and the full year, gaining 2.2% and 8.7% on an equal-weighted basis.
January 04, 2024
China Focus
Looking beyond China's year of 'dashed hopes'
Sentiment regarding China has gone too negative
December 20, 2023
Broker's Calls
Brokers’ Digest: StarHub, Nanofilm, ST Engineering, FHT, Sats
See what the analysts have to say this week.
November 19, 2023
Broker's Calls
Analysts mostly lift TPs on ComfortDelGro after further earnings recovery
Analysts are all keeping their "buy" and "add" calls on ComfortDelGro’s earnings of $49.9 million for the 3QFY2023 ended Sep 30.
November 17, 2023
Broker's Calls
Analysts mixed on DBS’s prospects with 'sell', 'neutral' and 'buy' calls after 3QFY2023 results
The analysts' target prices range from $29 to $44.28.
November 09, 2023